Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP GlobeNewswire December 01, 2025 December 1, 2025 Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of […]

Fitell Corporation Announces $3 Million Share Repurchase Program GlobeNewswire December 01, 2025 Taren Point, Australia, Dec. 01, 2025 (GLOBE NEWSWIRE) — Fitell Corporation (NASDAQ: FTEL) (“Fitell” or the “Company”) an online retailer of gym and fitness equipment in Australia, today announced that its board of directors (the “Board”) has approved a share repurchase program (the

BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress GlobeNewswire December 01, 2025 SUNNYVALE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces it will participate at the CSI Focus Devices

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride-PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants GlobeNewswire December 01, 2025 Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company, today

CytoDyn Announces Resolution of Class Action Lawsuit GlobeNewswire December 01, 2025 VANCOUVER, Washington, Dec. 01, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic triple-negative breast cancer (mTNBC) and

The Global Hydrocolloids Market: Why This Quiet Ingredient is Powering the Future of Food GlobeNewswire December 01, 2025 Delray Beach, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) — The global hydrocolloids market is on a steady rise, growing from USD 11.2 billion in 2023 to an expected USD 14.5 billion by 2028, at a CAGR of

Vancouver, British Columbia–(Newsfile Corp. – December 1, 2025) – Stardust Solar Energy Inc. (TSXV: SUN) (OTCQB: SUNXF) (“Stardust Solar” or the “Company“), a leading provider of residential solar energy solutions announces, further to its news releases of October 31, 2025, and November 12, 2025, that on November 28, 2025, the Company completed the second and

CougarD Releases New Relationship Trends Report Following Viral User Story That Sparked a Surge in Age-Gap Conversations GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — CougarD today announced the release of its new “Connection Beyond Age” Relationship Trends Report, a data-driven analysis prompted by a recent viral user post that reignited

Moomoo Engages 3.4 Million NYC Commuters with “Trade Smart” OOH Campaign for Q4 Earnings Season GlobeNewswire December 01, 2025 JERSEY CITY, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) — Moomoo, a leading global trading platform with 28 million users worldwide, has launched a strategic out-of-home (OOH) advertising campaign across New York City for the Q4 earnings

The following issues have been halted by CIRO Company: Storm Exploration Inc. TSX-Venture Symbol: STRM All Issues: Yes Reason: Pending News Halt Time (ET): 8:11 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and